IMI to hold third-quarter 2003 webcast and conference call on November 13 TORONTO, Nov. 7 /PRNewswire-FirstCall/ -- IMI International Medical Innovations Inc. (TSX:IMI, Amex:IME) will conduct a live webcast and conference call Thursday, November 13 at 10:30 a.m. to report its operating results and provide a corporate strategic update for the third fiscal quarter of 2003. The conference call, which will be open to the general public, will be chaired by IMI's President and CEO, Dr. Brent Norton, and will include Ron Hosking, Vice President and CFO, and Andrew Weir, Director, Communications. Date: Thursday, November 13, 2003 Time: 10:30 a.m. ET Web cast: http://www.imimedical.com/ Conference Call Numbers: (416) 695-5806 (Toronto area) (800) 273-9672 (North America toll free) Please call five minutes prior to the start time and specify the IMI call chaired by Dr. Brent Norton. Following its completion, a replay of the call can be accessed for three months on the IMI web site (http://www.imimedical.com/), or for one week by dialing (416) 695-5800 or (800) 408-3053 (U.S. & Canada) and entering access code 1494990. IMI is a world leader in predictive medicine, dedicated to developing rapid, non-invasive tests for the early detection and monitoring of life- threatening diseases, particularly cardiovascular disease and cancer. IMI's lead product is a non-invasive skin test for coronary artery disease. IMI's cancer products in development include ColorectAlert(TM), a screening test for colorectal cancer, LungAlert(TM), a screening test for lung cancer, and a new test for breast cancer. For further information, please visit the company's web site at http://www.imimedical.com/. DATASOURCE: IMI International Medical Innovations Inc. CONTACT: Andrew Weir, Director, Communications, (416) 222-3449 x27,

Copyright